• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪组织来源的间充质干细胞环境和 Wnt 拮抗作用对乳腺癌细胞系的抑制影响。

The inhibitory influence of adipose tissue-derived mesenchymal stem cell environment and Wnt antagonism on breast tumour cell lines.

机构信息

Stem Cell and Cancer Biology Laboratory, School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Western Australia, Australia.

Ear Sciences Centre, University of Western Australia, Western Australia, Australia.

出版信息

Int J Biochem Cell Biol. 2018 Feb;95:63-72. doi: 10.1016/j.biocel.2017.12.013. Epub 2017 Dec 19.

DOI:10.1016/j.biocel.2017.12.013
PMID:29277675
Abstract

Tumours exhibit a heterogeneous mix of cell types that reciprocally regulate their growth in the tumour stroma, considerably affecting the progression of the disease. Both adipose-derived mesenchymal stem cells and Wnt signalling pathway are vital in driving breast tumour growth. Hence, we examined the effect of secreted factors released by adipose-derived mesenchymal stem cells, and further explored the anti-tumour property of the Wnt antagonist secreted frizzled-related protein 4 (sFRP4) on MCF-7 and MDA-MB-231 breast tumour cells. We observed that conditioned medium and extracellular matrix derived from adipose-derived mesenchymal stem cells inhibited tumour viability. The inhibitory effect of the conditioned medium was retained within its low molecular weight and non-protein component. The conditioned medium also induced apoptosis accompanied by a decrease in the mitochondrial membrane potential in tumour cells, Furthermore, it downregulated the protein expression of active β-catenin and Cyclin D1, which are major target proteins of the Wnt signalling pathway, and reduced the expression of anti-apoptotic protein Bcl-xL. The combination of conditioned medium and sFRP4 further potentiated the effects, depending on the tumour cell line and experimental assay. We conclude that factors derived from conditioned medium of adipose-derived mesenchymal stem cells and sFRP4 significantly decreased the tumour cell viability and migration rates (MCF-7), accompanied with an enhanced apoptotic activity through inhibition of canonical Wnt signalling. Besides giving an insight to possible paracrine interactions and influence of signalling pathways, reflective of a breast tumour microenvironment, this study emphasises the utilization of cell free-secreted factors and Wnt antagonists to improve conventional anti-cancer strategies.

摘要

肿瘤表现出细胞类型的异质性混合,这些细胞类型在肿瘤基质中相互调节其生长,这极大地影响了疾病的进展。脂肪来源的间充质干细胞和 Wnt 信号通路在驱动乳腺癌生长方面都至关重要。因此,我们研究了脂肪来源的间充质干细胞释放的分泌因子的作用,并进一步探索了 Wnt 拮抗剂分泌卷曲相关蛋白 4(sFRP4)对 MCF-7 和 MDA-MB-231 乳腺癌细胞的抗肿瘤特性。我们观察到脂肪来源的间充质干细胞的条件培养基和细胞外基质抑制了肿瘤的活力。条件培养基的抑制作用保留在其低分子量和非蛋白质成分中。条件培养基还诱导了肿瘤细胞的凋亡,并伴有线粒体膜电位的降低。此外,它下调了 Wnt 信号通路的主要靶蛋白活性 β-连环蛋白和细胞周期蛋白 D1 的蛋白表达,并降低了抗凋亡蛋白 Bcl-xL 的表达。条件培养基和 sFRP4 的组合进一步增强了效果,这取决于肿瘤细胞系和实验测定。我们得出结论,脂肪来源的间充质干细胞的条件培养基和 sFRP4 衍生的因子显著降低了肿瘤细胞的活力和迁移率(MCF-7),并通过抑制经典 Wnt 信号通路增强了凋亡活性。除了深入了解可能的旁分泌相互作用和信号通路的影响,反映了乳腺癌的肿瘤微环境外,本研究还强调了利用无细胞分泌因子和 Wnt 拮抗剂来改善传统的抗癌策略。

相似文献

1
The inhibitory influence of adipose tissue-derived mesenchymal stem cell environment and Wnt antagonism on breast tumour cell lines.脂肪组织来源的间充质干细胞环境和 Wnt 拮抗作用对乳腺癌细胞系的抑制影响。
Int J Biochem Cell Biol. 2018 Feb;95:63-72. doi: 10.1016/j.biocel.2017.12.013. Epub 2017 Dec 19.
2
The Influence of Breast Tumour-Derived Factors and Wnt Antagonism on the Transformation of Adipose-Derived Mesenchymal Stem Cells into Tumour-Associated Fibroblasts.乳腺肿瘤衍生因子和Wnt拮抗作用对脂肪来源间充质干细胞向肿瘤相关成纤维细胞转化的影响
Cancer Microenviron. 2018 Jun;11(1):71-84. doi: 10.1007/s12307-018-0210-8. Epub 2018 Apr 10.
3
Perichondrium mesenchymal stem cells inhibit the growth of breast cancer cells via the DKK-1/Wnt/β-catenin signaling pathway.软骨膜间充质干细胞通过DKK-1/Wnt/β-连环蛋白信号通路抑制乳腺癌细胞的生长。
Oncol Rep. 2016 Aug;36(2):936-44. doi: 10.3892/or.2016.4853. Epub 2016 Jun 3.
4
Characteristics of human adipose mesenchymal stem cells isolated from healthy and cancer affected people and their interactions with human breast cancer cell line MCF-7 in vitro.从健康人和癌症患者中分离出的人脂肪间充质干细胞的特性及其与人类乳腺癌细胞系MCF-7的体外相互作用。
Cell Biol Int. 2014 Feb;38(2):254-65. doi: 10.1002/cbin.10198. Epub 2013 Nov 15.
5
Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.封装人间质干细胞(eMSCs)作为一种新型的针对乳腺癌干细胞的抗癌药物:3D 预刺激治疗性 MSCs 的开发。
Int J Biochem Cell Biol. 2019 May;110:59-69. doi: 10.1016/j.biocel.2019.02.001. Epub 2019 Feb 6.
6
EMILIN2 down-modulates the Wnt signalling pathway and suppresses breast cancer cell growth and migration.EMILIN2 下调 Wnt 信号通路,抑制乳腺癌细胞的生长和迁移。
J Pathol. 2014 Mar;232(4):391-404. doi: 10.1002/path.4316.
7
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation.自分泌WNT信号通过经典WNT途径和表皮生长因子受体(EGFR)反式激活促进乳腺癌细胞增殖。
Breast Cancer Res. 2007;9(5):R63. doi: 10.1186/bcr1769.
8
Peri-foci adipose-derived stem cells promote chemoresistance in breast cancer.灶周脂肪来源干细胞促进乳腺癌的化疗耐药性。
Stem Cell Res Ther. 2017 Jul 27;8(1):177. doi: 10.1186/s13287-017-0630-2.
9
Conditioned Medium from Adipose-Derived Stem Cells (ADSCs) Promotes Epithelial-to-Mesenchymal-Like Transition (EMT-Like) in Glioma Cells In vitro.脂肪来源干细胞(ADSCs)条件培养基促进体外神经胶质瘤细胞上皮-间充质样转化(EMT-like)。
Mol Neurobiol. 2016 Dec;53(10):7184-7199. doi: 10.1007/s12035-015-9585-4. Epub 2015 Dec 19.
10
Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration.间质干细胞衍生的白细胞介素-6 和血管内皮生长因子促进乳腺癌细胞迁移。
J Cell Biochem. 2012 Nov;113(11):3363-70. doi: 10.1002/jcb.24212.

引用本文的文献

1
Adipose-derived Stem Cells for Treatment of Diabetic Foot Ulcers: A Review.脂肪来源干细胞治疗糖尿病足溃疡:综述
Curr Stem Cell Res Ther. 2025;20(5):509-523. doi: 10.2174/011574888X334166240921120502.
2
Partial Inhibition of Epithelial-to-Mesenchymal Transition (EMT) Phenotypes by Placenta-Derived DBMSCs in Human Breast Cancer Cell Lines, In Vitro.胎盘来源的间充质干细胞对人乳腺癌细胞系上皮-间质转化(EMT)表型的体外部分抑制作用
Cells. 2024 Dec 23;13(24):2131. doi: 10.3390/cells13242131.
3
Harnessing the Therapeutic Potential of Mesenchymal Stem Cells in Cancer Treatment.
利用间充质干细胞在癌症治疗中的治疗潜力。
Adv Pharm Bull. 2024 Oct;14(3):574-590. doi: 10.34172/apb.2024.052. Epub 2024 Jun 22.
4
The secretome from human-derived mesenchymal stem cells augments the activity of antitumor plant extracts in vitro.人源间充质干细胞的分泌蛋白组在体外增强了抗肿瘤植物提取物的活性。
Histochem Cell Biol. 2024 May;161(5):409-421. doi: 10.1007/s00418-024-02265-1. Epub 2024 Feb 24.
5
Menstrual blood-derived endometrial stem cell, a unique and promising alternative in the stem cell-based therapy for chemotherapy-induced premature ovarian insufficiency.经血来源的子宫内膜干细胞,在基于干细胞的化疗诱导卵巢早衰治疗中是一种独特且有前景的选择。
Stem Cell Res Ther. 2023 Nov 13;14(1):327. doi: 10.1186/s13287-023-03551-w.
6
Preconditioned Chorionic Villus Mesenchymal Stem/Stromal Cells (CVMSCs) Minimize the Invasive Phenotypes of Breast Cancer Cell Line MDA231 In Vitro.预处理绒毛膜间质干细胞(CVMSCs)可减少体外乳腺癌细胞系 MDA231 的侵袭表型。
Int J Mol Sci. 2023 May 31;24(11):9569. doi: 10.3390/ijms24119569.
7
Eta polycaprolactone (ε-PCL) implants appear to cause a partial differentiation of breast cancer lung metastasis in a murine model.ε-聚己内酯(ε-PCL)植入物似乎在小鼠模型中引起乳腺癌肺转移的部分分化。
BMC Cancer. 2023 Apr 13;23(1):343. doi: 10.1186/s12885-023-10813-6.
8
TGF-B1-over-expressed adipose stem cells-derived secretome exhibits CD44 suppressor and anti-cancer properties via antagonistic effects against SMAD4 in breast cancer cells.转化生长因子β1过表达的脂肪干细胞来源的分泌组通过对乳腺癌细胞中SMAD4的拮抗作用表现出CD44抑制和抗癌特性。
Am J Stem Cells. 2022 Dec 25;11(5):64-78. eCollection 2022.
9
Decidua Parietalis Mesenchymal Stem/Stromal Cells and Their Secretome Diminish the Oncogenic Properties of MDA231 Cells In Vitro.蜕膜间充质干细胞及其分泌组体外降低 MDA231 细胞的致癌特性。
Cells. 2021 Dec 10;10(12):3493. doi: 10.3390/cells10123493.
10
Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications.基于间充质干细胞/基质细胞的治疗:精准临床应用的机制、系统安全性和生物分布。
J Biomed Sci. 2021 Apr 14;28(1):28. doi: 10.1186/s12929-021-00725-7.